Performance Characteristics for Some Typical QT Study Designs Under the ICH E‐14 Guidance
暂无分享,去创建一个
M. Hutmacher | M. Agin | R. Lalonde | J. Fleishaker | Matthew M Hutmacher | Sunny Chapel | Marilyn A Agin | Joseph C Fleishaker | Richard L Lalonde | S. Chapel
[1] Assessment of equivalence on multiple endpoints , 2001, Statistics in medicine.
[2] B. Efron. The jackknife, the bootstrap, and other resampling plans , 1987 .
[3] L. S. Fridericia. Die Systolendauer im Elektrokardiogramm bei normalen Menschen und bei Herzkranken , 2009 .
[4] R. Shah. Drugs, QT Interval Prolongation and ICH E14 , 2005, Drug safety.
[5] Borje Darpo,et al. Clinical Evaluation of QT/QTc Prolongation and Proarrhythmic Potential for Nonantiarrhythmic Drugs: The International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use E14 Guideline , 2006, Journal of clinical pharmacology.
[6] S. Patterson,et al. Investigating Drug-Induced QT and QTc Prolongation in the Clinic: A Review of Statistical Design and Analysis Considerations: Report from the Pharmaceutical Research and Manufacturers of America QT Statistics Expert Team , 2005 .
[7] Roger L. Berger,et al. Multiparameter Hypothesis Testing and Acceptance Sampling , 1982 .